Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07112781) titled 'Feasibility Trial of Single-Dose Radiotherapy for Localized Low and Intermediate Risk Prostate Cancer' on Aug. 2.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Branch Office of "Hadassah Medical Ltd"
Condition:
Prostate Cancer
Intervention:
Radiation: Single Dose Radiotherapy
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: July 24, 2024
Target Sample Size: 30
Countries of Recruitment:
Russian Federation
To know more, visit https://clinicaltrials.gov/ct2/...